C3H.C-Ankrd11Yod/H

Status

Available to order

EMMA IDEM:00380
Citation informationRRID:IMSR_EM:00380 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC3H.C-Ankrd11Yod/H
Alternative nameGENA110
Strain typeInduced Mutant Strains : Chemically-induced
Allele/Transgene symbolAnkrd11Yod
Gene/Transgene symbolAnkrd11

Information from provider

ProviderPat Nolan
Provider affiliationMRC Mammalian Genetics Unit
Genetic informationA GC-to-AT transition point mutations in exon 11 results in a glutamine to lysine substitution in a highly conserved residue in the encoded protein.
Phenotypic informationMice carrying the GENA110 mutation have craniofacial abnormalities and late on-set osteoporosis.
ReferencesNone available

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (allele matching)
  • decreased bone mineral density / IMPC
  • abnormal head morphology / IMPC
  • abnormal response to new environment / IMPC
  • abnormal retina vasculature morphology / IMPC
  • decreased heart weight / IMPC
  • decreased lean body mass / IMPC
  • increased total body fat amount / IMPC
  • increased bone mineral content / IMPC
IMPC phenotypes (gene matching)
  • decreased bone mineral density / IMPC
  • decreased startle reflex / IMPC
  • abnormal retina vasculature morphology / IMPC
  • decreased lean body mass / IMPC
  • increased circulating cholesterol level / IMPC
  • increased total body fat amount / IMPC
  • abnormal vitreous body morphology / IMPC
  • abnormal response to new environment / IMPC
  • decreased heart weight / IMPC
  • abnormal auditory brainstem response / IMPC
  • abnormal head morphology / IMPC
  • abnormal startle reflex / IMPC
  • increased bone mineral content / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • decreased prepulse inhibition / IMPC
  • decreased body length / IMPC
  • abnormal embryo development / IMPC
  • increased circulating HDL cholesterol level / IMPC
MGI phenotypes (allele matching)
  • decreased bone mineral density / MGI
  • abnormal nasal bone morphology / MGI
  • kyphosis / MGI
  • domed cranium / MGI
  • increased cranium width / MGI
  • decreased body length / MGI
  • decreased body weight / MGI
  • abnormal craniofacial bone morphology / MGI
  • abnormal bone structure / MGI
  • abnormal metopic suture morphology / MGI
  • decreased bone mass / MGI
  • short frontal bone / MGI
  • enlarged parietal bone / MGI
  • short nasal bone / MGI
  • decreased osteoclast cell number / MGI
  • decreased circulating leptin level / MGI
  • abnormal frontonasal suture morphology / MGI
  • decreased compact bone area / MGI
  • short face / MGI
  • broad face / MGI
  • decreased embryo size / MGI
  • failure of initiation of embryo turning / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
MGI phenotypes (gene matching)
  • decreased bone mineral density / MGI
  • abnormal nasal bone morphology / MGI
  • kyphosis / MGI
  • domed cranium / MGI
  • increased cranium width / MGI
  • decreased body length / MGI
  • decreased body weight / MGI
  • decreased embryo size / MGI
  • abnormal craniofacial bone morphology / MGI
  • abnormal bone structure / MGI
  • abnormal metopic suture morphology / MGI
  • decreased bone mass / MGI
  • failure of initiation of embryo turning / MGI
  • short frontal bone / MGI
  • enlarged parietal bone / MGI
  • short nasal bone / MGI
  • decreased osteoclast cell number / MGI
  • decreased circulating leptin level / MGI
  • abnormal frontonasal suture morphology / MGI
  • decreased compact bone area / MGI
  • embryonic lethality during organogenesis, complete penetrance / MGI
  • short face / MGI
  • broad face / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).